Researchers say collective results highlight the therapeutic potential of enhancing IL-10+ monocytes for treating sex-biased pain conditions.

Italian biathlete Rebecca Passler was handed a provisional suspension after testing positive for a banned substance ahead of the Winter Olympics.

The BTD for zovegalisib is supported by data from the Phase I/II ReDiscover trial.

Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of zovegalisib in combination ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the ...

Scroll through Instagram or TikTok long enough and you’ll almost certainly see enthusiasts for special diets, supplements, or a 30-day lifestyle overhaul with promises that they’ll “reset” your ...

Disruptions to our circadian clocks—the internal molecular timekeepers "ticking" in nearly every cell of our body throughout the day—can lead to a wide range of health problems, from sleep ...

For years, hormone therapy (HT) had earned a bad rep it just couldn’t shake. Many women who might have benefited never even considered the treatment, thrown off by the Food & Drug Administration's ...

Women are dramatically more likely than men to suffer from irritable bowel syndrome (IBS), a chronic condition causing abdominal pain, bloating, and digestive discomfort. Now, scientists at UC San ...

What if there were a straightforward and relatively inexpensive way to lower the incidence of heart failure (HF), renal disease, stroke, and cognitive impairment? Cardiologist Bertram Pitt, MD, said ...